Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

46.63
+0.16000.34%
Post-market: 46.62-0.0117-0.03%17:25 EST
Volume:11.59M
Turnover:538.04M
Market Cap:94.93B
PE:15.70
High:47.00
Open:46.41
Low:45.96
Close:46.47
52wk High:63.33
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.52
T/O Rate:0.57%
Dividend:2.48
Dividend Rate:5.32%
EPS(TTM):2.97
EPS(LYR):-4.4144
ROE:33.78%
ROA:9.39%
PB:5.12
PE(LYR):-10.56

Loading ...

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

THOMSON REUTERS
·
Nov 03

Bristol-Myers Squibb Co - Offers to Purchase up to $3 Bln in Some Securities

THOMSON REUTERS
·
Nov 03

Bristol Myers files automatic mixed securities shelf

TIPRANKS
·
Nov 01

Bristol-Myers Squibb's Lack of Update on Phase 3 Alzheimer's Trial 'Surprising,' Morgan Stanley Says

MT Newswires Live
·
Oct 31

Bristol-Myers Squibb: Balancing Strong Product Performance with Market Challenges and Patent Pressures

TIPRANKS
·
Oct 31

Morgan Stanley Sticks to Its Sell Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
Oct 31

Cantor Fitzgerald Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
Oct 31

Morgan Stanley Raises Price Target on Bristol-Myers Squibb to $36 From $34, Keeps Underweight Rating

MT Newswires Live
·
Oct 31

Bristol Myers Squibb Co. Stock Rallies 7.1%, Outperforms Peers

Dow Jones
·
Oct 31

Bristol Myers' New Treatments Drive Q3 Beat — And The Company's Raising Its Outlook

Benzinga
·
Oct 31

Bristol-Myers Squibb on Track for Largest Percent Increase Since November 2024

Dow Jones
·
Oct 31

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

Reuters
·
Oct 31

Market Chatter: Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids

MT Newswires Live
·
Oct 31

Stock Track | Bristol-Myers Squibb Soars 5.23% on Strong Q3 Earnings, Raised Guidance

Stock Track
·
Oct 30

Bristol-Myers Squibb Exec Says Sales of Reblozyl Annualizing at Over $2 Bln, Breyanzi at Over $1 Bln and Camzyos at Over $1 Bln - Conf Call

THOMSON REUTERS
·
Oct 30

Earnings Flash (BMY) Bristol-Myers Squibb Posts Q3 Revenue $12.2B, vs. FactSet Est of $11.81B

MT Newswires Live
·
Oct 30

Bristol-Myers Squibb Q3 Adj. EPS $1.63 Beats $1.51 Estimate, Sales $12.222B Beat $11.814B Estimate

Benzinga
·
Oct 30

Bristol Myers beats quarterly revenue estimates on strong Opdivo sales

Reuters
·
Oct 30

Press Release: Bristol Myers Squibb Reports Third Quarter Financial Results for 2025

Dow Jones
·
Oct 30

Bristol Myers Q3 REV $12.22 Bln VS Ibes Estimate $11.81 Bln

THOMSON REUTERS
·
Oct 30